D
Like Score · tier D7qualityScore▲1 · 7d
PriceFree
Reviews16091% positive
Inbound MLT4peers liking this
Lifetime units—no estimate
StatusLiveVery Positive
Sales estimate not available yet
Free-to-play title. Our sales estimator only covers paid games — F2P revenue (mostly DLC + microtransactions) needs a different methodology.
How sales estimation works →01 Like Score
qualityScore = Σ inbound · log₁₀(reviews+1) · positive% · rank-bonus
Tier D · ▲ 1 7d
D ●CBAS
Inbound
4
×
Σ log₁₀(R+1)
5
Avg pos%
43%
→ 7
Score history · 30d retention
6 (13d ago)7 (now)
02 Top inbound contributors
Games whose “More Like This” lists rank Forbidden Terror: Board Game · 4 inbound · top 4 shown
qualityScore 7
03 Forbidden Terror: Board Game’s “More like this”
Outbound MLT · 30 games
Review score
8/ 9
% positive
92.4%cohort 71%
Total reviews
157tracked
Velocity · 30d
0 / dayest
Steam-purchase rate
100.0%flat
01 Language distribution
Reviewer interface language · count, share of total, share positive
18 languages · top 12 shown
ENEnglish59.9%9493%
RURussian12.1%19100%
DEGerman5.7%978%
ZHSimplified Chinese3.2%580%
FRFrench3.2%5100%
ESSpanish2.5%4100%
PLPolish2.5%4100%
TRTurkish1.9%3100%
PTBrazilian Portuguese1.3%2100%
UKUkrainian1.3%250%
CZCzech1.3%2100%
ESLatin American Spanish1.3%2100%
02 Reviews by playtime
Hours played at time of review · positive% per bucket
0-1h 124
93%positive
1-10h 32
91%positive
10-100h 1
100%positive
03 Monthly timeline
Reviews per month · positive vs negative stacked · since launch
Positive 145Negative 12
624731160
25·1025·1125·1226·0126·0226·0326·04
04 Breakdowns
Reviews segmented · count, % of total, % positive
157 reviews
Free product
0/ 157
0.0% of total— no data
Early access
0/ 157
0.0% of total— no data
Key activation
0/ 157
0.0% of total— no data
Steam Deck
0/ 157
0.0% of total— no data
Steam purchase
157/ 157
100.0% of total92% positive
Recommended
145/ 157
92.4% of total— votedUp
Not recommended
12/ 157
7.6% of total— votedDown
Reviews crawled
157/ 157
100.0% of total92% positive
160 reviews · 91% positive
Detailed reviewer overlap is being computed. Check back soon.